Inhibitors: Diagnostic challenges, unknowns of inhibitor development, treatment of bleeding and surgery, and insights into diagnosis and treatment in China.

Escuriola Ettingshausen, Carmen; Yang, Renchi; Wu, Wenman; Meeks, Shannon L

Escuriola Ettingshausen, Carmen; Yang, Renchi; Wu, Wenman; Meeks, Shannon L.

Afiliação

Escuriola Ettingshausen C; HZRM Hemophilia Center Rhine-Main, Frankfurt-Mörfelden, Mörfelden-Walldorf, Germany.
Yang R; State Key Laboratory of Experimental Hematology, National Clinical Research Center for Blood Diseases, Institute of Hematology & Blood Diseases Hospital, Chinese Academy of Medical Sciences & Peking Union Medical College, Tianjin, China.
Wu W; Department of Laboratory Medicine, Ruijin Hospital affiliated to Shanghai Jiaotong University School of Medicine, Shanghai, China.
Meeks SL; Aflac Cancer and Blood Disorders Center of Children's Healthcare of Atlanta and Department of Pediatrics, Emory University, Atlanta, Georgia, USA.

Haemophilia ; 28 Suppl 4: 111-118, 2022 May.

Article em En | MEDLINE | ID: mdl-35521731

Assuntos

Hemofilia A; Fator IX/uso terapêutico; Fator VIII/uso terapêutico; Hemofilia A/diagnóstico; Hemofilia A/tratamento farmacológico; Hemorragia/diagnóstico; Hemorragia/tratamento farmacológico; Hemorragia/prevenção & controle; Humanos; Tolerância Imunológica; Proteínas Recombinantes/uso terapêutico

Palavras-chave

bypassing agents; haemophilia; immune tolerance; inhibitors

Texto completo

Imprimir

XML

PubMed Links

Buscar no Google

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Hemofilia A Tipo de estudo: Diagnostic_studies Limite: Humans Idioma: En Ano de publicação: 2022 Tipo de documento: Article

Texto completo

Imprimir

XML

PubMed Links

Buscar no Google